02 January, 2008 |
| 11:18 |
Seasons Greetings |
A. D'Emanuele |
03 January, 2008 |
| 22:30 |
[RegAffairs]QC reporting to production |
Globepharm /MAnisfeld |
04 January, 2008 |
| 07:55 |
[RegAffairs]RE: QC reporting to production |
Tilak-Kumar Sha |
| 07:55 |
[RegAffairs]Re: QC reporting to production |
Yongliang Tou |
| 07:55 |
[RegAffairs]RE: QC reporting to production |
Rick Flora |
| 18:43 |
[RegAffairs]Re: QC reporting to production |
bruce berger |
| 23:38 |
[RegAffairs]Re: QC reporting to production |
TJMULLINS |
05 January, 2008 |
| 14:21 |
[RegAffairs]Re: QC reporting to production |
Jim Tyrrell |
16 January, 2008 |
| 22:06 |
[RegAffairs]Re: QC reporting to production |
Ketan Agravat |
| 22:06 |
[RegAffairs]UK Reg Affairs Professional Societies |
Globepharm /MAnisfeld |
| 22:09 |
[RegAffairs]Re: QC Reporting to Production |
Jean-Denis Mallet |
| 22:39 |
[RegAffairs]RE: UK Reg Affairs Professional Societies |
Lassoff, Peter |
02 February, 2008 |
| 22:52 |
[RegAffairs]Neomycin and Bacitracin topical aerosol |
Bojan |
03 February, 2008 |
| 11:26 |
[RegAffairs]Re: Neomycin and Bacitracin topical aerosol |
Globepharm /MAnisfeld |
| 12:36 |
[RegAffairs]Re: Neomycin and Bacitracin topical aerosol |
Zdravko Mauko, FARMAVITA |
07 February, 2008 |
| 06:17 |
[RegAffairs]Black eye for US Pharma Industry |
Globepharm /MAnisfeld |
| 13:16 |
[RegAffairs]Re: Black eye for US Pharma Industry |
Malcolm Ross |
21 February, 2008 |
| 18:15 |
[RegAffairs]Mutual Recognition Procedure - TGA & EMEA |
thirumurugan gopalasamy |
| 20:00 |
[RegAffairs]RE: Mutual Recognition Procedure - TGA & EMEA |
Steve Binysh |
22 February, 2008 |
| 10:12 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Jim Tyrrell |
| 15:57 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
thirumurugan gopalasamy |
23 February, 2008 |
| 00:06 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Brian MATTHEWS |
| 14:54 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Steve Binysh |
| 22:25 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Brian MATTHEWS |
25 February, 2008 |
| 09:11 |
[RegAffairs]Translation of patient questionnaire |
Ruthy Batish |
| 18:14 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
thirumurugan gopalasamy |
| 20:04 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EME |
Malcolm Ross |
26 February, 2008 |
| 18:21 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Jim Tyrrell |
| 18:26 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Jim Tyrrell |
| 18:46 |
[RegAffairs]Sunset Clause in France |
Nicola Nestor |
27 February, 2008 |
| 08:44 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Steve Binysh |
| 09:29 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Jim Tyrrell |
| 11:37 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Steve Binysh |
| 15:59 |
[RegAffairs]Re: Mutual Recognition Procedure - TGA & EMEA |
Hahn, Klaus |
01 March, 2008 |
| 08:51 |
[RegAffairs]Submitting US dossier to EU |
Rajaneesh.br |
02 March, 2008 |
| 08:22 |
[RegAffairs]Re: Submitting US dossier to EU |
Lassoff, Peter |
| 08:52 |
[RegAffairs]Re: Submitting US dossier to EU |
Malcolm Ross |
| 08:52 |
[RegAffairs]Re: Sunset Clause in France |
Malcolm Ross |
| 11:01 |
[RegAffairs]Re: Submitting US dossier to EU |
lt09 |
| 11:01 |
[RegAffairs]Labelling |
sekhar chandu |
| 18:53 |
[RegAffairs]Re: Submitting US dossier to EU |
Jim Tyrrell |
06 March, 2008 |
| 20:20 |
[RegAffairs]Holding time and mean kinetic temperature |
Aleksandra |
07 March, 2008 |
| 14:34 |
[RegAffairs]Re; Labelling problems for less developed markets |
Steve Binysh |
08 March, 2008 |
| 08:49 |
[RegAffairs]Re: Labelling |
rajaneesh B R |
09 March, 2008 |
| 11:39 |
[RegAffairs]Re: Labelling |
sekhar chandu |
11 March, 2008 |
| 11:10 |
[RegAffairs]Re: Holding time and mean kinetic temperature |
aks |
12 March, 2008 |
| 10:06 |
[RegAffairs]SA Clinical trials |
Swapnil Salaskar |
13 March, 2008 |
| 08:27 |
[RegAffairs]Re: Holding time and mean kinetic temperature |
Kate |
| 14:29 |
[RegAffairs]Re: Holding time and mean kinetic temperature |
aks |
| 14:29 |
[RegAffairs]Re: Number of subjects for Clinical trials in SA |
shakeel |
| 22:43 |
[RegAffairs]Holding Time and Kinetic Mean Temperature |
Lassoff, Peter |
14 March, 2008 |
| 07:03 |
[RegAffairs]EU GMP certification |
Kirti Rawal |
| 18:19 |
[RegAffairs]Re: EU GMP certification |
Brian MATTHEWS |
| 18:21 |
[RegAffairs]RE: EU GMP certification |
Ketan Agravat |
| 18:23 |
[RegAffairs]Re: Holding Time and Kinetic Mean Temperature |
Malcolm Ross |
| 18:23 |
[RegAffairs]RE: EU GMP certification |
Steve Binysh |
| 21:36 |
[RegAffairs]Re: EU GMP certification |
Jim Tyrrell |
15 March, 2008 |
| 05:55 |
[RegAffairs]Re: EU GMP certification |
williex52-aa |
| 05:55 |
[RegAffairs]Re: EU GMP certification |
Ketan Agravat |
| 07:10 |
[RegAffairs]Re: EU GMP certification |
Brian MATTHEWS |
| 07:41 |
[RegAffairs]Re: EU GMP certification |
Ketan Agravat |
16 March, 2008 |
| 13:11 |
[RegAffairs]Re: Holding Time and Kinetic Mean Temperature |
Aleksandra |
| 19:25 |
[RegAffairs]Re: Holding Time and Kinetic Mean Temperature |
Lassoff, Peter |
17 March, 2008 |
| 07:19 |
[RegAffairs]Re: EU GMP certification |
Kirti Rawal |
| 22:26 |
[RegAffairs]Re: Holding Time and Kinetic Mean Temperature |
Kate |
26 March, 2008 |
| 16:38 |
[RegAffairs]Medication guide |
PAKHI RUSIA |
| 21:32 |
[RegAffairs]Reg Requirements for US shipping to Israel |
Gerry Hara |
| 22:36 |
[RegAffairs]Re: Reg Requirements for US shipping to Israel |
Malcolm Ross |
03 April, 2008 |
| 05:47 |
[RegAffairs]Excipient DMF |
Frank w |
| 06:31 |
[RegAffairs]Re: Excipient DMF |
Sreejith_Kurup |
| 06:36 |
[RegAffairs]Re: Excipient DMF |
Vamsikanth A |
| 06:55 |
[RegAffairs]Re: Excipient DMF |
NiravChokshi |
06 April, 2008 |
| 08:57 |
[RegAffairs]Re: Excipient DMF |
Malcolm Ross |
08 April, 2008 |
| 07:06 |
[RegAffairs]Re: Excipient DMF |
Yongliang Tou |
09 April, 2008 |
| 21:07 |
[RegAffairs]OTC Products - Schedule?? |
thirumurugan gopalasamy |
| 21:47 |
[RegAffairs]Re: OTC Products - Schedule?? |
Rick Flora |
10 April, 2008 |
| 06:32 |
[RegAffairs]Re: OTC Products - Schedule?? |
thirumurugan gopalasamy |
| 12:33 |
[RegAffairs]Analytical method for unspecified & total impurities |
rajaneesh B R |
11 April, 2008 |
| 08:19 |
[RegAffairs]Re: Analytical method for unspecified & totalimpurities |
Malcolm Ross |
12 April, 2008 |
| 11:56 |
[RegAffairs]RE:Analytical method for unspecified & totalimpurities |
rajaneesh B R |
14 April, 2008 |
| 08:37 |
[RegAffairs]Re: Analytical method for unspecified & totalimpurities |
Frank w |
| 09:43 |
[RegAffairs]Re: Analytical method for unspecified & totalimpurities |
Yongliang Tou |
21 April, 2008 |
| 07:05 |
[RegAffairs]Site representative |
Yongliang Tou |
| 09:14 |
[RegAffairs]Methotrexate (MTX) in Cell Bank |
Leanne Amitzi |
28 April, 2008 |
| 08:35 |
[RegAffairs]Amoxicillin Trihydrate - MRL (Maximum Residue Limit)and ADI (Acceptable Daily Intake)". |
Satish Kapoor |
| 10:55 |
[RegAffairs]Labelling Requirement |
Susan Jeffrey |
| 11:25 |
[RegAffairs]Re: Labelling Requirement] |
lee.bridgen |
| 11:30 |
[RegAffairs]Re: Labelling Requirement |
lt09 |
29 April, 2008 |
| 15:48 |
[RegAffairs]Residual Levels of Methotrexate |
Leanne Amitzi |
30 April, 2008 |
| 06:52 |
[RegAffairs]Re: Residual Levels of Methotrexate |
Frank W |
| 09:42 |
[RegAffairs]Lanthanum salts as finished dosage forms |
sanjay shetgar |
| 10:41 |
[RegAffairs]Re: Labelling Requirement |
Vincent Kuanyin Agoth Wek |
05 May, 2008 |
| 13:38 |
[RegAffairs]Same molecule, multiple strengths, multipleapplication nos. |
kams |
07 May, 2008 |
| 12:49 |
[RegAffairs]Re: Same molecule, multiple strengths, multiple |
Hatice Atkaya |
| 20:37 |
[RegAffairs]Data exclusivity |
Hatice Atkaya |
08 May, 2008 |
| 15:10 |
[RegAffairs]Re: Data exclusivity |
lee.bridgen |
| 20:14 |
[RegAffairs]Re: Data exclusivity |
Malcolm Ross |
09 May, 2008 |
| 13:55 |
[RegAffairs]I™LT : Data exclusivity |
Hatice Atkaya |
| 21:26 |
[RegAffairs]RE: ITLT : Data exclusivity |
Steve Binysh |
12 May, 2008 |
| 13:52 |
[RegAffairs]RE: Same molecule, multiple strengths, multipleapplication nos. |
Globepharm /MAnisfeld |
